Alpha-synuclein mRNA expression in oligodendrocytes in MSA.

Area of Science:

• Neuroscience
• Genetics
• Pathology

Background:

• Multiple System Atrophy (MSA) is a progressive neurodegenerative disease characterized by parkinsonian, cerebellar, and autonomic dysfunction.
• Alpha-synuclein (αsyn) aggregates, forming glial cytoplasmic inclusions (GCIs), are a hallmark of MSA, but the mechanisms of αsyn accumulation remain unclear.

Purpose of the Study:

• To investigate regional and cellular messenger RNA (mRNA) expression of the SNCA gene in postmortem brain samples from patients with MSA.
• To explore whether alterations in SNCA mRNA expression contribute to the formation of GCIs in MSA.

Main Methods:

• Quantitative reverse transcription polymerase chain reaction (qPCR) was used to measure SNCA mRNA levels in brain regions (frontal, occipital, putamen, pons, cerebellum) and isolated cells (neurons, oligodendrocytes) from MSA, idiopathic Parkinson's disease (IPD), and control cases.
• Laser-capture microdissection was employed for cellular expression analysis.

Main Results:

• No significant differences in overall SNCA mRNA expression were found between MSA, IPD, and control groups across all examined brain regions.
• Significant regional variations in SNCA mRNA expression were observed, with higher levels in the occipital cortex and lower levels in the putamen.
• Oligodendrocytes in MSA brains showed a trend towards increased SNCA mRNA expression compared to controls, though this did not reach statistical significance.

Conclusions:

• Regional differences in SNCA mRNA expression exist in the human brain, with higher expression in cortical areas.
• This study provides the first evidence of SNCA mRNA expression in human oligodendrocytes using qPCR.
• Although not statistically significant, the observed trend of increased SNCA mRNA in MSA oligodendrocytes warrants further investigation into their role in GCI formation.